» Authors » P Amarenco

P Amarenco

Explore the profile of P Amarenco including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 135
Citations 3390
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ducrocq G, Bhatt D, Labreuche J, Corbalan R, Porath A, Gao R, et al.
Eur J Prev Cardiol . 2013 Aug; 21(12):1509-16. PMID: 23965467
Aims: There are major differences in the prevalence and management of patients with atherothrombotic disease including coronary artery disease (CAD), cerebrovascular disease (CVD) and peripheral artery disease (PAD) across different...
2.
Amarenco P, Bogousslavsky J, Caplan L, Donnan G, Wolf M, Hennerici M
Cerebrovasc Dis . 2013 Aug; 36(1):1-5. PMID: 23899749
ASCO phenotyping (A: atherosclerosis; S: small-vessel disease; C: cardiac pathology; O: other causes) assigns a degree of likelihood of causal relationship to every potential disease (1 for potentially causal, 2...
3.
Touboul P, Hennerici M, Meairs S, Adams H, Amarenco P, Bornstein N, et al.
Cerebrovasc Dis . 2012 Nov; 34(4):290-6. PMID: 23128470
Intima-media thickness (IMT) provides a surrogate end point of cardiovascular outcomes in clinical trials evaluating the efficacy of cardiovascular risk factor modification. Carotid artery plaque further adds to the cardiovascular...
4.
Giles M, Albers G, Amarenco P, Arsava E, Asimos A, Ay H, et al.
Neurology . 2011 Aug; 77(13):1222-8. PMID: 21865578
Objectives: Stroke risk immediately after TIA defined by time-based criteria is high, and prognostic scores (ABCD2 and ABCD3-I) have been developed to assist management. The American Stroke Association has proposed...
5.
Steg P, Dorman S, Amarenco P
J Thromb Haemost . 2011 Jul; 9 Suppl 1:325-32. PMID: 21781269
Atherothrombosis remains a major global public health problem. Chronic atherosclerotic disease is often clinically silent and coexists across vascular beds, but when complicated by thrombosis can result in acute coronary...
6.
Slaoui T, Klein I, Guidoux C, Cabrejo L, Meseguer E, Abboud H, et al.
Neurology . 2010 Mar; 74(13):1030-2. PMID: 20200339
Background: A substantial proportion of ischemic strokes have an embolic mechanism, but the source of embolism is not detected. Coexistence of subdiaphragmatic visceral infarction (SDVI; e.g., renal, splenic, hepatic, bowel...
7.
Jabiri M, Mazighi M, Meimoun P, Amarenco P
Cerebrovasc Dis . 2010 Jan; 29(3):309-10. PMID: 20110674
No abstract available.
8.
Mazighi M, Labreuche J, Amarenco P
Int J Stroke . 2009 Sep; 4(5):346-51. PMID: 19765122
Background: Hyperglycaemia in the acute phase of stroke has been established as a predictor of higher mortality. But recent data regarding active treatment of hyperglycaemia showed no clinical benefit suggesting...
9.
Amarenco P
Int J Stroke . 2009 Aug; 4(3):185-6. PMID: 19659820
No abstract available.
10.
Bousser M, Amarenco P, Chamorro A, Fisher M, Ford I, Fox K, et al.
Cerebrovasc Dis . 2009 May; 27(6):608-13. PMID: 19407444
Background: The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study is an international...